How one venture firm is working to unlock MedTech; Where J&J/Shockwave is taking IVL next
In this episode of DeviceTalks Weekly, Managing Editor Kayleen Brown takes the helm leading a keynote interview with Jenny Barba, co-founder of Features Capital. Barba shares her path into venture capital, identifies winning strategies for start-ups, and highlights some of the more exciting companies in the Features Capital portfolio.
A special thanks to this episode’s sponsor, SHL Healthcare, for supporting DeviceTalks! Go to www.shl-healthcare.com for more information. As a special bonus, download SHL Healthcare’s complimentary white paper highlighting the outcomes of using the combination of advanced sewing, welding, and electromechanical assembly here: https://www.devicetalks.com/wp-content/uploads/2026/02/SHL-Healthcare_Whitepaper_Integrated-Approach.pdf
Kayleen Brown also leads our FOMO interview with Nick West, MD, chief medical officer of Shockwave Medical, part of Johnson & Johnson MedTech. They talk about the future calcium modification, intravascular lithotripsy, and the evolving treatment of vascular disease.
We’ll start things off with Host Tom Salemi and Chris Newmarker of MassDevice reviewing the newsmakers of the week – BioVentrix, Medical 21, VB Spine, Augmedics, Medtronic, Danaher, and Masimo.
***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
